Tianshi Capital
Investment Details
Investor Type
Family Office
Asset Class Focus
Venture Capital, Private Equity
Stage Focus
Seed, Early Stage, Series A
Geographical Focus
United States, Europe, China
Industries Focus
- Healthcare
- Agriculture
- Life Sciences
- Pharmaceuticals
- Biotechnology
Investment Size:
1,000,000 to 2,000,000 USD
Investor Details Founded: 2021
Tianshi Capital is an international family office specializing in early-stage investments within the life sciences sector. The firm focuses on angel to Series A investments, typically ranging from $1 million to $2 million USD. Their portfolio encompasses companies in healthcare IT, biotechnology, pharmaceuticals, and agriculture.
The founders of Tianshi Capital have over 30 years of experience in building and selling life sciences companies, including pharmaceutical, clinical research, and drug development firms. They are also primary shareholders in various health care IT, biotech, pharmaceutical, and agriculture businesses.
Tianshi Capital's investment strategy emphasizes identifying and nurturing innovative companies with high growth potential in the life sciences industry, aiming to drive advancements in healthcare and related fields.
Requirements
- Innovative business models
- Strong management teams
- Scalable growth potential
- Alignment with life sciences sector
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Mentioned In
Claim this Investor
Are you an official representative of Tianshi Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim